What We Know About the Omicron Variant
University experts in infectious disease, epidemiology, pediatrics, and global health share insights related to Omicron, which the World Health Organization has labeled a variant of concern.
N.J.’s health system is failing underserved groups. How can the care divide be bridged?
Institute director Richard Marlink discusses social determinants of health in this NJ.com story about the Commonwealth Fund’s new report, “Achieving Racial and Ethnic Equity in U.S. Health Care: A Scorecard of State Performance.”
Building a pipeline to replenish the supply of primary care doctors in N.J.
WHYY.org features the perspectives of New Jersey Medical School students Sebastian Acevedo and Angelica Lopez and assistant dean Ana Natale-Pereira related to a new scholarship program for medical students from underserved communities to become primary care physicians in Newark and surrounding towns.
COVID-19 Vaccine Receives Emergency Use Authorization for Children 5 to 11
Rutgers faculty member Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses questions about the vaccine rollout for this age group.
Rutgers Faculty Doctor Selected for National Training Program to Promote Diversity in Clinical Trials
Radiation oncologist Malcolm Mattes of Rutgers Cancer Institute of New Jersey is one of 52 physicians nationwide joining the Diversity in Clinical Trials Career Development Program, a five-year, $100 million initiative launched by Bristol Myers Squibb Foundation and partners.